Alivus Life Sciences Ltd. IPO

It is a wholly-owned subsidiary of Glenmark Pharma and the leading manufacturer of selected APIs in chronic therapeutic areas.

Open Demat Account

Alivus Life Sciences Ltd. IPO Details

Check out the issue details for Alivus Life Sciences Ltd. IPO as disclosed in SEBI.

IPO Price

₹ 720

Price Band

₹ 695 - 720

Issue Size

1,513.60 Cr.

Issue Type

Book Built

Open

2021-07-27

Close

2021-07-29

Listing price

₹ 750

Listing Gain

4.17%

Listing Date

2021-08-06

CMP

₹ 1369

Current Return

90.14%

Company Financials

You can get the following financial statements of Alivus Life Sciences Ltd. as of now.

The valuation of Glenmark Life Sciences IPO company based on its price band and RHP is:

Particulars Value
Upper Price Band Rs 720
Total Shares 12.25 Cr
Market Cap 8820 Cr
EPS  Rs 28.69 
PE Ratio 25x
Industry PE 37x

 

Glenmark Life Sciences IPO issue size is 1513.6 Cr. 

Issue Amount
Fresh Issue 1060 Cr
Offer For Sale 453.6 Cr

 

An Individual can apply for a minimum 1 lot of 20 shares and a maximum of 13 lots of 260 shares. Find the details below:

Application Lot Shares Amount
 Minimum  1 20 Rs 14,400
 Maximum 13 260 Rs 1,87,200

 

Glenmark Life Sciences IPO is subscribed 44.17 times till 29th July. It is Oversubscribed as of now. The category-wise subscription is as follows:

Category % Offered Subscription 
Qualified Institutional Maximum 50% 36.97 Times
Non-Institutional Minimum 15% 122.54 Times
Retail Individual Minimum 35% 14.63 Times
Total 100% 44.17 Times

Once you have subscribed to an IPO, you have to wait for its allotment to your account. Find below the dates of allotment of Glenmark Life Sciences IPO:

Schedule Date
Basis of Allotment 03 August 2021
Refunds 04 August 2021
Credit to Demat Account 05 August 2021
IPO Listing Date 06 August 2021

When the allotment is out, you can check it from the registrar's website. Find the Glenmark Life Sciences IPO allotment status here.

Check allotment status

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 2123.21 2161.22 2283.21 2386.88 2551.83
Total Expenditure 1507.15 1518.93 1608.97 1704.3 1754.55
Operating Profit 616.06 642.29 674.25 682.58 797.28
Other Income 14.7 28.96 12.04 34.57 60.41
Interest 27.96 0.55 1.55 2.41 5.37
Depreciation 37.88 42.09 53.45 60.61 75.36
Exceptional Items 0 0 0 0 -25.66
Profit Before Tax 564.93 628.61 631.29 654.13 751.31
Provision for Tax 146.2 161.65 160.4 168.5 186.83
Net Profit 418.72 466.96 470.89 485.63 564.48
Adjusted EPS (Rs.) 3.42 3.81 3.84 3.96 4.6

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 24.51 24.51 24.51 24.51 24.55
Total Reserves 2029.81 2113.7 2307.82 2792.87 3307.59
Borrowings 0 0 0 0 0
Other N/C liabilities 32.7 67.4 756.95 466.05 142.73
Current liabilities 746.8 1014.89 438.77 470.16 682.24
Total Liabilities 2833.81 3220.49 3528.05 3753.59 4157.1
Assets
Net Block 589.76 780.63 805.06 954.95 1037.55
Capital WIP 91.69 49.35 101.19 94.25 273.4
Intangible WIP 5.27 12.26 4.8 7.66 10.35
Investments 0.08 0.08 0.08 0.08 0.08
Loans & Advances 19.63 9.49 700.92 361.49 12.16
Other N/C Assets 0 0 0 0 0
Current Assets 2127.39 2368.68 1916 2335.16 2823.56
Total Assets 2833.81 3220.49 3528.05 3753.59 4157.1
* Other Non-current Liabilities include Net deferred Liabilities

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Other Income 8.99 14.72 13.93 22.78 22.4
Profit Before Tax 162.98 174.14 198.39 215.8 212.22
Tax 41.45 44.11 48.13 53.14 52.15
Profit After Tax 121.54 130.03 150.26 162.66 160.08
Adjusted EPS (Rs) 9.91 10.6 12.25 13.25 13.04

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2026 74.87 0
Mar 2026 74.87 0
Dec 2025 74.91 0
Sep 2025 74.91 0
Jun 2025 74.94 0
* Figures given above are % of equity capital

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 564.93 628.61 631.29 654.13 751.31
Adjustment 70.99 44.62 79.27 80.72 115.9
Changes in Assets & Liabilities 99.84 -213.66 -134.08 -180.38 -128.54
Tax Paid -138.17 -153.57 -162.96 -162.95 -173.26
Operating Cash Flow 597.59 306.01 413.52 391.52 565.41
Investing Cash Flow -122.23 -146.75 -116.48 -615.65 -570.15
Financing Cash Flow -78.8 -387.59 -279.44 -6.23 -64.34
Net Cash Flow 396.56 -228.33 17.59 -230.35 -69.08
X